Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01694784 · ClinicalTrials.gov registry record · NA
Understanding and Discouraging Overuse of Potentially Harmful Screening Tests
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 775
- Enrollment target
NCT01694784 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 775 participants.
The verdict
NCT01694784, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 775 participants
- Enrollment target
Study Summary
Most prevention efforts focus on promoting services (e.g. vaccination, screening tests). While some of these services have clear net benefit, many instead have possible or clear net harm. Currently, three quarters of services graded by the U.S. Preventive Services Task Force (USPSTF) have possible or clear net harm (C, I, and D services). Many of these services are delivered in healthcare settings at higher rates than what might be expected based on their potential for harm. This leads to adverse outcomes, excess costs, and missed opportunities to deliver more quality care. An important issue in delivering prevention messages is how to shift toward a focus on the appropriateness of prevention: encouraging services with clear net benefit and either discouraging or reducing demand for services with possible or clear net harm. Unfortunately, little is known about what drives overuse of potentially harmful screening services or how to make harms relevant to patients. This randomized controlled trial (RCT) of 775 patients at 4 primary care practices aims to 1) assess factors associated with intent to receive possibly or clearly harmful screening services and 2) determine whether and how patients' plans to get screened change with various presentations of information about harms (e.g. qualitative, quantitative, narrative, framed). The investigators will focus on three types of screening services: osteoporosis screening (previous C recommendation and now no recommendation for women \< 65 years old with no fracture risk factors), prostate-specific antigen (PSA) screening (D recommendation for all men, regardless of age), and colorectal cancer (CRC) screening (C for ages 76-85).
Interventions
- BEHAVIORAL Quantitative Information Sheet
- BEHAVIORAL Qualitative Information Sheet
- BEHAVIORAL Narrative Information Sheet
- BEHAVIORAL Framed Information Sheet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 775 participants |
| Start Date | 2012-09 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01694784
The ClinicalTrials.gov registry entry for NCT01694784 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 775 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Quantitative Information Sheet is the first listed.
NCT01694784 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01694784 about?
NCT01694784 is a clinical study titled "Understanding and Discouraging Overuse of Potentially Harmful Screening Tests". Most prevention efforts focus on promoting services (e.g. vaccination, screening tests). While some of these services have clear net benefit, many instead have possible or clear net harm. Currently, three quarters of services graded by the U.S. Preventive Services Task Force (USPSTF) have possible o...
What is the current status of trial NCT01694784?
This trial is currently completed. It is a NA study. The enrollment target is 775 participants. The study started on 2012-09. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01694784?
The interventions under investigation include: Quantitative Information Sheet (BEHAVIORAL), Qualitative Information Sheet (BEHAVIORAL), Narrative Information Sheet (BEHAVIORAL), Framed Information Sheet (BEHAVIORAL).
Who is sponsoring clinical trial NCT01694784?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.